Summit Therapeutics to Present at the JMP Securities Life Sciences Conference

Oxford, June 15, 2018 (GLOBE NEWSWIRE) -- Oxford, UK, and Cambridge, MA, US, 15 June 2018 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces that Glyn Edwards, Chief Executive Officer, will present at the JMP Securities Life Sciences Conference on 21 June 2018 at 9:30am EDT in New York City.

A live audio webcast of the presentation will be available through the Investors section on the Company's website, www.summitplc.com. A replay of the webcast will be available from the same location soon after the live presentation.

About Summit Therapeutics Summit is a biopharmaceutical company focused on the discovery, development and commercialisation of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease, Duchenne muscular dystrophy, and the infectious disease, Clostridium difficile infection. Further information is available at www.summitplc.com and Summit can be followed on Twitter (@summitplc).

For more information, please contact:

-END-

You May Also Be Interested In

• Family Federation for World Peace and Unification Leads Hundreds in Las Vegas Prayer Vigil for the Mother of Peace Ahead of South Korea Verdict
• Avanti Gold Announces Bought Deal Private Placement, Board Restructuring and Annual General Meeting
• Top Meme Coin AI Predictions 2026: MemeToro MT, TRUMP, Pepecoin, Dogecoin, AlphaPepe and Shiba Inu